Form 4: Saba Capital Management Reduces Stake in BlackRock Capital Allocation Term Trust
SEC Form 4
Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust, has reported selling shares of common stock over two days.
Summary
- Saba Capital Management, L.P., a significant shareholder in BlackRock Capital Allocation Term Trust (BCAT), has filed a Form 4 detailing changes in their beneficial ownership.
- On March 6, 2025, Saba Capital sold 34,340 shares of BCAT common stock at a price of $15.3 per share.
- Following this transaction, Saba Capital's indirectly held beneficial ownership decreased to 12,130,163 shares.
- On March 7, 2025, Saba Capital sold 40,113 shares of BCAT common stock at a price of $15.18 per share.
- Following this transaction, Saba Capital's indirectly held beneficial ownership decreased to 12,090,050 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports a transaction without expressing any opinion or forward-looking statements.
Industry Context
Hedge funds like Saba Capital Management frequently adjust their positions in closed-end funds like BCAT to manage their portfolios and capitalize on market opportunities.
Stakeholder Impact
- The sale of shares by a major shareholder like Saba Capital could potentially influence the market price of BCAT shares in the short term.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Saba Capital sold 34,340 shares at $15.3. |
| 03/07/2025 | Saba Capital sold 40,113 shares at $15.18. |
| 03/10/2025 | Date of form signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.